Inspire Medical ( INSP ) is a medical technology company that offers the only device that has been approved by the FDA for patients with obstructive sleep apnea ("OSA"). At a conference in early 2023, the chief executive officer said that the "biggest challenge" in generating revenue for company's OSA device was patients getting an appointment with a doctor to be evaluated and receive prior authorization. To meet that challenge and increase demand for the device, the company introduced a pilot program under which company employees coordinated with customers to directly access doctors' electronic schedules and schedule doctor appointments online, without the need for phone calls. The company made repeated public statements as to the effectiveness of the pilot program and that it achieved a "30% improvement in physician appointments."